These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1492027)
1. [Problems of chronic heart failure]. Tkaczewski W Pol Arch Med Wewn; 1992; 88(2-3):200-6. PubMed ID: 1492027 [No Abstract] [Full Text] [Related]
2. [Pathomechanisms of heart failure]. Urbaszek W Z Arztl Fortbild (Jena); 1993; 87(8 Suppl 4):1-4. PubMed ID: 8105608 [No Abstract] [Full Text] [Related]
3. [Heart failure, summary and perspectives]. Just H Z Kardiol; 1992; 81 Suppl 4():105-8. PubMed ID: 1290286 [No Abstract] [Full Text] [Related]
4. [Treatment of heart failure: what--when--how?]. Blömer H Verh Dtsch Ges Inn Med; 1990; 96():157-67. PubMed ID: 2092435 [No Abstract] [Full Text] [Related]
5. Pathophysiological considerations in selecting vasodilator therapy for CHF. Cohn JN Acta Med Scand Suppl; 1981; 652():93-7. PubMed ID: 6949468 [No Abstract] [Full Text] [Related]
6. When should we use nitrates in congestive heart failure? Vizzardi E; Bonadei I; Rovetta R; D'Aloia A; Quinzani F; Curnis A; Dei Cas L Cardiovasc Ther; 2013 Feb; 31(1):27-31. PubMed ID: 22953723 [TBL] [Abstract][Full Text] [Related]
8. [Value of ACE inhibitors in heart failure (clinical aspects)]. Riegger AJ Z Kardiol; 1992; 81 Suppl 4():93-6. PubMed ID: 1290309 [TBL] [Abstract][Full Text] [Related]
9. [Response to the letter by K. Kochsiek, Würzburg]. Beuckelmann D; Erdmann E Internist (Berl); 1994 Nov; 35(11):1084. PubMed ID: 7822132 [No Abstract] [Full Text] [Related]
10. Symposium on vasodilator and inotropic therapy of heart failure. Symposium perspective. Mason DT Am J Med; 1978 Jul; 65(1):101-5. PubMed ID: 356597 [No Abstract] [Full Text] [Related]
11. [Use of nitroglycerin in the treatment of congestive heart failure]. Curyło AM Folia Med Cracov; 1989; 30(1-2):23-9. PubMed ID: 2518363 [TBL] [Abstract][Full Text] [Related]
12. [Effect of clophelin on the hemodynamics of patients with circulatory insufficiency]. Akhmedkhanov SSh; Pomerantsev VP; Vasiuk IuA Sov Med; 1984; (11):67-71. PubMed ID: 6523213 [No Abstract] [Full Text] [Related]
13. Outflow resistance as a regulator of left ventricular performance. Franciosa JA Angiology; 1978 May; 29(5):393-401. PubMed ID: 655470 [No Abstract] [Full Text] [Related]
14. [Therapy of chronic heart failure with vasodilator agents]. Zähringer J; Schultheiss HP Internist (Berl); 1986 May; 27(5):315-21. PubMed ID: 3015822 [No Abstract] [Full Text] [Related]
15. Mechanisms and quantitative assessment of drug effects on cardiac output with a new model of the circulation. Greenway CV Pharmacol Rev; 1981 Dec; 33(4):213-51. PubMed ID: 7041140 [No Abstract] [Full Text] [Related]
17. [Heart failure: from physiopathology to treatment. II. Treatment]. Batlouni M Arq Bras Cardiol; 1991 Aug; 57(2):151-67. PubMed ID: 1823774 [No Abstract] [Full Text] [Related]
18. [Clinical study of the preparation korvatone]. Charchoglian RA; Esin NN; Belozerov GE Sov Med; 1982; (5):15-8. PubMed ID: 7051350 [No Abstract] [Full Text] [Related]
19. Principles of treatment of left ventricular failure. Taylor SH; Silke B; Nelson GI Eur Heart J; 1982 Dec; 3 Suppl D():19-43. PubMed ID: 6761126 [No Abstract] [Full Text] [Related]
20. [Cardiac pre- and poststress in circulatory failure in postinfarct cardiosclerosis patients]. Ol'binskaia LI Kardiologiia; 1987 Dec; 27(12):5-7. PubMed ID: 3444214 [No Abstract] [Full Text] [Related] [Next] [New Search]